In light of the evidences reported here we thought that our data offer clues to better explore CAV1 isoforms in tumors, thus providing new opportunities to improve both treatment and prognosis of triple-negative breast cancer. This evidence concerns the gene CAV1 and triple-negative breast carcinoma.